Enavate Sciences Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
5
- Investments
-
21
- Portfolio
-
8
- Exits
-
9
Enavate Sciences General Information
Company Description
Founded in 2022, Enavate Sciences is a venture capital firm based in New York. The firm seeks to invest in health tech, information technology, digital health and life sciences.
Business Details
Website
www.enavatesciences.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 106 West 56th Street
- 8th Floor
- New York, NY 10019
- United States
Enavate Sciences Investments (21)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Ambros Therapeutics | 21-Aug-2026 | PIPE | Biotechnology | Clinical Trials - Phase 3 | ||
| AirNexis Therapeutics | 09-Jan-2026 | Biotechnology | Clinical Trials - Phase 1 | |||
| Ambros Therapeutics | 16-Dec-2025 | Biotechnology | Clinical Trials - Phase 3 | |||
| Braveheart Bio | 05-Nov-2025 | Drug Discovery | Generating Revenue/Not Profitable | |||
| Normunity | 24-Sep-2025 | Drug Discovery | Clinical Trials - Phase 1 | |||
| BridgeBio Oncology Therapeutics | 11-Aug-2025 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Aviceda Therapeutics | 07-Jan-2025 | Biotechnology | Clinical Trials - Phase 2 | |||
| OrsoBio | 28-Aug-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Zenas BioPharma | 03-May-2024 | Later Stage VC | Drug Discovery | Generating Revenue | ||
| BridgeBio Oncology Therapeutics | 30-Apr-2024 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 1 |
Enavate Sciences Exits (9)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Braveheart Bio | 06-Aug-2026 | IPO | |
| Zenas BioPharma | 26-Mar-2026 | ||
| Compass Therapeutics | 13-Aug-2025 | ||
| Sionna Therapeutics | 06-Feb-2025 | ||
| CAMP4 | 11-Oct-2024 | ||
| Upstream Bio | 11-Oct-2024 | ||
| Zenas BioPharma | 13-Sep-2024 | IPO | |
| Alladapt Immunotherapeutics | 23-Jul-2024 | Bankruptcy: Liquidation |
Enavate Sciences Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Enavate Sciences Co-Investors (103)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| OrbiMed | 5 |
|
|
||
| Longitude Capital |
|
|
|||
| Frazier Healthcare Partners |
|
|
|||
| Omega Funds |
|
|
|||
| Wellington Management |
|
|
Enavate Sciences FAQs
-
What is Enavate Sciences?
Founded in 2022, Enavate Sciences is a venture capital firm based in New York.
-
When was Enavate Sciences founded?
Enavate Sciences was founded in 2022.
-
Where is Enavate Sciences headquartered?
Enavate Sciences is headquartered in New York, NY.
-
How many investments has Enavate Sciences made?
Enavate Sciences has made 21 investments.
-
What has Enavate Sciences invested in?
Enavate Sciences has made numerous investments in companies like Ambros Therapeutics, AirNexis Therapeutics, and Braveheart Bio within the Biotechnology and Drug Discovery industries.
-
What has Enavate Sciences invested in recently?
Enavate Sciences's latest investment was on 21-Aug-2026 in Ambros Therapeutics, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
